文献速递急性肾损伤

毛细血管渗漏综合征:病因、病理生理与治疗

Capillary leak syndrome: etiologies, pathophysiology, and management.
PubMed 文献 · Kidney Int · 2017-03-17

本文综述了脓毒症以外可导致毛细血管渗漏综合征的疾病,包括特发性系统性毛细血管渗漏综合征或Clarkson病、植入综合征、分化综合征、卵巢过度刺激综合征、噬血细胞性淋巴组织细胞增生症、病毒性出血热、自身免疫性疾病、蛇咬伤中毒和蓖麻毒素中毒,以及某些白介素、单克隆抗体和吉西他滨等药物。急性肾损伤在这些疾病中常见,细胞因子可能在其病理生理中起重要作用。液体管理是治疗的关键部分,低血容量和低血压可导致器官损伤,而输液后的毛细血管渗漏可加重器官水肿。

要点

  • 脓毒症以外多种疾病和药物可导致毛细血管渗漏综合征。
  • 急性肾损伤在这些疾病中常见,细胞因子可能参与其病理生理。
  • 液体管理是关键,需平衡低血容量所致器官损伤与输液加重水肿的风险。

核心结论

  • 本文讨论了脓毒症以外产生毛细血管渗漏的疾病,并综述其共同的病理生理与治疗。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • 多种疾病可导致毛细血管渗漏综合征,表现为弥漫性凹陷性水肿、渗出性浆膜腔积液、非心源性肺水肿、低血压,部分病例出现低血容量性休克伴多器官衰竭。
  • 可引起毛细血管渗漏综合征的疾病包括特发性系统性毛细血管渗漏综合征或Clarkson病、植入综合征、分化综合征、卵巢过度刺激综合征、噬血细胞性淋巴组织细胞增生症、病毒性出血热、自身免疫性疾病、蛇咬伤中毒和蓖麻毒素中毒。
  • 药物如某些白介素、某些单克隆抗体和吉西他滨也可引起毛细血管渗漏综合征。
  • 急性肾损伤在所有这些疾病中常见,除低血压外,细胞因子可能在毛细血管渗漏综合征中急性肾损伤的病理生理中起重要作用。
  • 液体管理是治疗毛细血管渗漏综合征的关键部分,低血容量和低血压可导致器官损伤,而给予的液体经毛细血管渗漏可加重器官水肿,导致进行性器官损伤。

临床怎么用

  • 液体管理是毛细血管渗漏综合征治疗的关键部分,需权衡低血容量和低血压所致器官损伤与输液经毛细血管渗漏加重器官水肿的风险。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In various human diseases, an increase in capillary permeability to proteins leads to the loss of protein-rich fluid from the intravascular to the interstitial space. Although sepsis is the disease most commonly associated with this phenomenon, many other diseases can lead to a "sepsis-like" syndrome with manifestations of diffuse pitting edema, exudative serous cavity effusions, noncardiogenic pulmonary edema, hypotension, and, in some cases, hypovolemic shock with multiple-organ failure. The term capillary leak syndrome has been used to describe this constellation of disease manifestations associated with an increased capillary permeability to proteins. Diseases other than sepsis that can result in capillary leak syndrome include the idiopathic systemic capillary leak syndrome or Clarkson's disease, engraftment syndrome, differentiation syndrome, the ovarian hyperstimulation syndrome, hemophagocytic lymphohistiocytosis, viral hemorrhagic fevers, autoimmune diseases, snakebite envenomation, and ricin poisoning. Drugs including some interleukins, some monoclonal antibodies, and gemcitabine can also cause capillary leak syndrome. Acute kidney injury is commonly seen in all of these diseases. In addition to hypotension, cytokines are likely to be important in the pathophysiology of acute kidney injury in capillary leak syndrome. Fluid management is a critical part of the treatment of capillary leak syndrome; hypovolemia and hypotension can cause organ injury, whereas capillary leakage of administered fluid can worsen organ edema leading to progressive organ injury. The purpose of this article is to discuss the diseases other than sepsis that produce capillary leak and review their collective pathophysiology and treatment.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Siddall E, Khatri M, Radhakrishnan J, et al. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017. PMID: 28318633. doi:10.1016/j.kint.2016.11.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。